Status:

COMPLETED

Effects of Pet Therapy on Pain in Cancer Patients

Lead Sponsor:

National Institutes of Health Clinical Center (CC)

Conditions:

Cancer

Eligibility:

All Genders

18-110 years

Phase:

PHASE2

Brief Summary

This study will examine how animal-assisted therapy (AAT) affects aspects of pain. It will explore the possible benefits of the National Institutes of Health's AAT program on distress in cancer patien...

Detailed Description

The purpose of this study is to evaluate the effectiveness of the NIH Animal-Assisted Therapy (AAT) program on distress in oncology patients treated for pain. More than simply a physiologic or sensory...

Eligibility Criteria

Inclusion

  • ELIGIBILITY CRITERIA:
  • All adult cancer patients enrolled in research protocols who have a pain and palliative care consult, or a recreation therapy consult at the NIH Clinical Center may be eligible for the current study. Since the AAT provided at the NIH Clinical Center is generally available to the heterogeneous cancer population (with the exception of neutropenic patients) and the primary outcome of interest is distress regardless of the type of cancer, a heterogenous sample of cancer patients is considered appropriate for this investigation. While adults are the target population for this pilot study, if results are encouraging, minors will be considered for inclusion in subsequent studies.
  • INCLUSION CRITERIA:
  • Ability to speak English and read at a 5th grade level
  • 18 years of age or older
  • Able to give informed consent
  • Consulted to pain and palliative care team and Recreation Therapy
  • Diagnosis of cancer
  • Available to be at the CRC on two consecutive days in the morning hours.
  • EXCLUSION CRITERIA:
  • Interruption of primary protocol
  • Allergies to or fear of dogs
  • Patient on strict contact, or respiratory isolation restrictions
  • Neutropenic patients

Exclusion

    Key Trial Info

    Start Date :

    February 4 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 21 2018

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT00431639

    Start Date

    February 4 2005

    End Date

    December 21 2018

    Last Update

    April 11 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892